D-1581-2019 Class II Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

Recall Details

Product Type
Drugs
Report Date
July 31, 2019
Initiation Date
July 19, 2019
Termination Date
September 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,832 bottles

Product Description

Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02

Reason for Recall

Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #:H801815, Exp. March 2021